Three Out of Four

A peer-reviewed study of trekkers on Mount Kilimanjaro (Karinen et al., 2008) found that 75% developed acute mountain sickness. A second study by Davies et al. using stricter Lake Louise scoring criteria put the number at 77%. Not 77% of the unfit. Not 77% of the underprepared. Seventy-seven percent of the total study population, which included experienced hikers following standard ascent profiles.

Kilimanjaro (5,895m) delivers roughly 49% of sea-level oxygen at the summit. That number does not change based on fitness, willpower, or how much the climb cost.

Sources: PubMed 19115914 — Karinen et al., 2008, PubMed 20030437 — Davies et al.

What AMS, HAPE, and HACE Actually Are

Acute Mountain Sickness (AMS) is the mild end: headache, nausea, fatigue, dizziness, poor sleep. It hits most climbers above 4,000m. Annoying, manageable, and a warning signal. AMS itself rarely kills anyone. What kills people is ignoring it.

High Altitude Pulmonary Edema (HAPE) is fluid accumulation in the lungs. Symptoms: breathlessness at rest, wet cough, gurgling breathing, blue lips. It accounts for 76% of altitude fatalities on Kilimanjaro. Onset can be rapid — a climber functioning normally at dinner can be drowning in their own fluid by midnight.

High Altitude Cerebral Edema (HACE) is swelling of the brain. Symptoms: confusion, loss of coordination (ataxia), irrational behavior, hallucinations. It progresses to coma and death within hours if the climber does not descend. HACE is rarer than HAPE but more lethal once established.

A two-year survey at Kilimanjaro Christian Medical Centre found that among altitude patients admitted: 54% had HAPE, 12% had HACE, 20% had both, and 76% required inpatient care.

Sources: PubMed 33431301 — KCMC hospital survey, Climbing-Kilimanjaro.com — Deaths

Why Acclimatization Days Matter More Than Fitness

The single most counterintuitive fact about Kilimanjaro: a marathon runner on a 5-day route has worse odds than a moderately fit trekker on an 8-day route.

The data is unambiguous:

Route	Duration	Summit Success Rate
Marangu	5 days	27%
Machame	6 days	~50%
Machame	7 days	~70%
Lemosho	7 days	~85%
Lemosho	8 days	~90%
Northern Circuit	9 days	95%+

Source: Ultimate Kilimanjaro — KINAPA Success Rate Data

The difference between 27% and 90% is not gear, guides, or genetics. It is time. The human body needs days — not hours — to increase red blood cell production, elevate its ventilatory response, and adjust hemoglobin oxygen affinity. You cannot train this at sea level. You cannot buy it. You can only wait for it.

The overall cross-route success rate on Kilimanjaro is roughly 65%. One in three climbers who start the mountain fail to summit. The primary variable is acclimatization time.

The per-day fee trap

This is where economics collides with physiology. TANAPA charges park fees per day — $70 conservation + $50 camping = $120/day before 18% VAT. The difference between a 5-day Marangu and an 8-day Lemosho is $450-500 in park fees alone. Budget climbers — the ones most sensitive to cost — are systematically funneled toward shorter routes with dramatically worse acclimatization profiles. The fee structure incentivizes the behavior that causes most failures and medical emergencies.

Source: Altezza Travel — Park Fees 2026

Climb High, Sleep Low

The phrase sounds like folklore. It is the single most validated principle in altitude medicine.

"Climb high, sleep low" means ascending to a higher altitude during the day, then descending to sleep at a lower camp. This exposes the body to reduced oxygen pressure — triggering acclimatization — while allowing recovery at a more forgiving altitude overnight.

How route profiles differ

Machame and Lemosho build this principle into their itinerary. On the Machame route, day 4 involves climbing from Barranco Camp (3,960m) up the Barranco Wall to Karanga Valley (3,995m), after having slept at Lava Tower altitude (4,630m) the day before. The profile oscillates deliberately: up, down, up higher, down less. The body adapts.

Marangu does not. It follows a straight-up trajectory: gate (1,860m) to Mandara (2,720m) to Horombo (3,720m) to Kibo (4,700m) to summit (5,895m). Every night is higher than the last. There is no descent-and-recovery cycle. This is why the 5-day Marangu fails three out of four climbers.

Lemosho and Northern Circuit routes add an extra day or two at moderate altitude (Shira Plateau, 3,600-3,800m) before the push above 4,000m. This buys time at the exact altitude band where acclimatization yield is highest.

The route choice is the acclimatization strategy. They are not separate decisions.

Sources: Climb Kilimanjaro Guide — Acclimatization, Altezza Travel — Acclimatization

Diamox: What It Does and What It Doesn't

Acetazolamide (brand name Diamox) is a carbonic anhydrase inhibitor. It works by making the blood slightly more acidic, which tricks the brain into increasing ventilation rate — breathing faster and deeper. This accelerates the body's natural acclimatization response.

CDC recommendation

The CDC Yellow Book recommends 125mg twice daily, starting the day before ascent begins and continuing through the highest sleeping altitude. The CDC classifies Kilimanjaro as a high-risk destination with a 30-40% AMS incidence (a conservative estimate — peer-reviewed studies put it at 50-77%).

What Diamox does

Accelerates ventilatory acclimatization that normally takes 3-5 days to approximately 1 day
Reduces AMS symptom severity
Improves sleep quality at altitude (it counteracts periodic breathing)
Functions as a mild diuretic, reducing fluid retention

What Diamox does not do

Mask symptoms of serious altitude illness. This is a persistent myth. Diamox treats mild AMS; it does not suppress HAPE or HACE warning signs.
Replace acclimatization time. It accelerates adaptation; it does not eliminate the need for it. A 5-day route with Diamox is still worse than a 7-day route without it.
Guarantee anything. Some climbers respond poorly to acetazolamide. Others experience side effects severe enough to stop taking it.

Side effects

Tingling in the fingers, toes, and lips (paresthesia) — nearly universal and harmless. Increased urination. Altered taste — carbonated drinks taste flat. Rarely: nausea, drowsiness, or allergic reaction (cross-reactivity with sulfa allergies, though the risk is low).

Prescription requirements

Diamox requires a prescription in most countries including the United States, UK, and EU. It does not require a prescription in Tanzania and can be purchased over the counter in Moshi pharmacies — but starting a new medication on the mountain without prior tolerance testing is poor practice. Get the prescription at home. Do a trial run before the trip.

Sources: CDC Yellow Book — High Altitude, Altezza Travel — Diamox

Summit Night Physiology

Summit night is not a hike. It is a controlled physiological crisis.

The standard protocol: leave high camp (Barafu at 4,673m or Kibo at 4,700m) between midnight and 2:00 AM. Climb 1,100-1,200 vertical meters on loose volcanic scree. Reach Stella Point (5,756m) or Uhuru Peak (5,895m) by sunrise. Descend to high camp. Continue descending to a lower camp. Total moving time: 12-16 hours.

The conditions

Temperature: -15 to -25C (-4 to -13F) at altitude, with wind chill pushing perceived temperature to -30C or lower
Oxygen: 49% of sea-level partial pressure at the summit
Visibility: Complete darkness for the first 5-7 hours; headlamp illumination only
Terrain: Steep, loose volcanic scree and gravel that slides underfoot
Duration: 6-8 hours of continuous uphill effort before reaching the crater rim

The midnight start exists for two reasons. First, the scree is partially frozen at night, making footing slightly more stable. Second, reaching the summit at sunrise allows time to descend before afternoon weather closes in — and before the cumulative altitude exposure becomes dangerous.

At 5,895m, the body is operating under severe hypoxic stress. Heart rate elevates. Cognitive function degrades. Simple decisions — put on gloves, drink water, keep walking — require disproportionate effort. Many climbers describe summit night as the hardest physical experience of their lives, not because of the exertion, but because of the oxygen deficit making every step feel like the last.

Sources: Follow Alice — Summit Night, Peak Planet — Summit Night Experience

Pulse Oximetry: What Guides Monitor

Reputable operators measure blood oxygen saturation (SpO2) and heart rate twice daily using a pulse oximeter clipped to the finger.

At sea level, healthy SpO2 is 95-99%. On Kilimanjaro, expected readings decline with altitude:

Altitude	Typical SpO2 Range
3,000m	90-95%
4,000m	85-92%
4,700m (high camp)	78-88%
5,895m (summit)	65-80%

These numbers are individual. A fit 25-year-old might read 82% at high camp and feel fine. A 55-year-old might read 85% and be severely symptomatic. Guides track trends, not absolutes. A sudden drop of 5+ points from one reading to the next, or SpO2 consistently below 70% at rest, triggers a descent decision regardless of how the climber says they feel.

The limitation: pulse oximetry alone does not diagnose HAPE or HACE. It is one data point alongside the Lake Louise AMS questionnaire, gait assessment (can the climber walk a straight line?), and clinical judgment. Budget operators who do not carry pulse oximeters are cutting a safety corner that costs $30.

Sources: Ultimate Kilimanjaro — Daily Health Checks, Climbing-Kilimanjaro.com — Pulse Oximeter

Deaths on Kilimanjaro

Official figures: 3-10 tourist deaths per year among approximately 69,000 annual climbers (2024/2025 season). A mortality rate of roughly 0.03%.

These numbers are unreliable.

KINAPA (Kilimanjaro National Park Authority) maintains the records but does not publish them. The most rigorous study — Hauser et al., examining autopsies from 1996-2003 — found 25 tourist deaths over 8 years, approximately 3 per year. But climber numbers have more than doubled since that period. A proportional estimate for 2025 would be 6-10 tourist deaths per year.

Porter and crew deaths are estimated at roughly double the tourist rate — approximately 20 per year — but post-mortem examination is not compulsory for crew, and many deaths go unreported. The total body count on Kilimanjaro is likely 25-30 per year across tourists and crew.

The primary cause of death is HAPE (76% of fatalities). Not falls. Not exposure. Fluid in the lungs from ascending too fast.

Sources: CMK — Death Statistics, Climbing-Kilimanjaro.com — Deaths

The December 2025 helicopter crash

On December 24, 2025, a KiliMedair Aviation rescue helicopter (Airbus H125) crashed between Barafu Camp and Kibo Summit at approximately 4,000m while evacuating altitude-sick climbers. All five people on board were killed: the pilot, a local doctor, a tour guide, and two Czech climbers who had been picked up in a medical evacuation.

This was not an altitude death. It was an infrastructure death. Kilimanjaro's rescue system relies on helicopter evacuation for serious cases, and helicopter operations at 4,000-5,000m in variable mountain weather carry inherent risk. The crash forced a recalibration of how climbers and operators assess rescue reliability — the backup plan itself can fail.

The Tanzania Civil Aviation Authority opened an investigation. As of April 2026, findings have not been published.

Sources: Al Jazeera — Kilimanjaro Helicopter Crash, Altezza Travel — Helicopter Crash

Rescue Infrastructure: What Actually Happens When Things Go Wrong

There are two evacuation methods on Kilimanjaro:

Stretcher carry. Park rangers and guides load the climber onto a wheeled stretcher called a "kilimobile" and physically carry or roll them down the mountain. This is included in the $20 rescue fee paid with park entry. It works. It is slow — descent from high camp to the gate can take 8-12 hours. For HAPE or HACE, those hours matter.

Helicopter evacuation. Available from companies like KiliMedair (the same operator involved in the December 2025 crash). Response time is advertised at 15 minutes from distress call, though actual response depends on weather, daylight, and aircraft availability. Helicopter operations are viable up to approximately 6,000m. Cost: $5,000-10,000 USD per evacuation.

Insurance requirements

Standard travel insurance does not cover Kilimanjaro. Most policies cap altitude coverage at 3,000m. A Kilimanjaro-specific policy must explicitly include:

Trekking coverage to 6,000m altitude
Helicopter evacuation (not just "emergency transport")
Medical treatment and hospitalization in Tanzania
Emergency repatriation

Minimum recommended coverage: $50,000+ for medical and evacuation combined. Providers that reliably cover Kilimanjaro include Global Rescue, World Nomads (with adventure sports add-on), and IMG. Verify altitude and helicopter clauses in writing before departure — verbal confirmation from a call center is insufficient.

Most operators will not allow a climber to start the trek without proof of adequate insurance.

Sources: Team Kilimanjaro — Travel Insurance, Duma Explorer — Helicopter Evacuation Guide

What This Means

Kilimanjaro's altitude problem is not mysterious. The physiology is well understood. The solutions are known. The data has been published in peer-reviewed journals for nearly two decades.

The fix is time. More days on the mountain. A route profile that climbs high and sleeps low. Diamox as a supplement, not a substitute. A guide with a pulse oximeter and the authority to turn climbers around. Insurance that covers the full altitude range and helicopter evacuation.

The obstacle is not medical knowledge. It is economics. TANAPA's per-day fee structure makes the safest routes the most expensive. Budget pressure pushes climbers toward 5-day itineraries where three out of four will fail. Operator marketing claims "95% success rates" that no independent data supports. And the rescue infrastructure — as December 2025 demonstrated — is not infallible.

Seventy-seven percent of climbers get sick on this mountain. The ones who summit are not the fittest. They are the ones who bought enough days.